Celestone soluspan and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Celestone soluspan (betamethasone acetate; betamethasone sodium phosphate), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Clonazepam, and have Back pain.

The phase IV clinical study analyzes which people have Fall when taking Celestone soluspan. It is created by eHealthMe based on reports of 712 people who have side effects when taking Celestone soluspan from the FDA, and is updated regularly.

What is Celestone soluspan?

Celestone soluspan has active ingredients of betamethasone acetate; betamethasone sodium phosphate. eHealthMe is studying from 721 Celestone soluspan users. Check the latest studies of Celestone soluspan.

What is Fall?

Fall is found to be associated with 3,286 drugs and 3,753 conditions by eHealthMe. Check the latest studies of Fall.

On Dec, 31, 2025

712 people reported to have side effects when taking Celestone soluspan.
Among them, 16 people (2.25%) have Fall.

Among these 16 people:

How long have people been on Celestone soluspan when they have Fall? *

What is the gender of people who have Fall when taking Celestone soluspan? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Fall when taking Celestone soluspan? *

What are other drugs people take besides Celestone soluspan? *

What are other side effects people have besides Fall? *

Dizziness: 9 people, 56.25%
Loss Of Consciousness: 8 people, 50.00%
Fainting (loss of consciousness and postural tone): 7 people, 43.75%
Pain: 7 people, 43.75%
Insomnia (sleeplessness): 6 people, 37.50%
Headache (pain in head): 6 people, 37.50%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 31.25%
Back Pain: 5 people, 31.25%
Drug Ineffective: 5 people, 31.25%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 25.00%

What are the existing conditions these people have? *

Stress And Anxiety: 3 people, 18.75%
Optic Neuritis (optic nerve inflammation): 3 people, 18.75%
Crying: 3 people, 18.75%
Back Pain: 3 people, 18.75%
Pain: 2 people, 12.50%
Neuralgia (pain in one or more nerves): 2 people, 12.50%
Joint Pain: 2 people, 12.50%
Intervertebral Disc Protrusion (spinal disc protrusion): 2 people, 12.50%
High Blood Pressure: 2 people, 12.50%
Emotional Disorder: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Celestone soluspan and have Fall?

- Check whether Fall is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celestone soluspan:

Celestone soluspan (721 reports)

Fall treatments and more:

Fall (403,513 reports)

How severe was Fall and when was it recovered:

Fall in Celestone soluspan

Expand to all the drugs that have ingredients of betamethasone acetate; betamethasone sodium phosphate:

Fall and drugs with ingredients of betamethasone acetate; betamethasone sodium phosphate (328 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celestone soluspan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,286 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,753 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone acetate; betamethasone sodium phosphate (the active ingredients of Celestone soluspan) and Celestone soluspan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.